Editorial: ustekinumab during pregnancy - reassuring but still not enough

Aurelien Amiot^{1

2}, Antoine Meyer^{1

2}, Franck Carbonnel^{1

2}

Affiliations

¹ Department of Gastroenterology, Hôpitaux Universitaires Bicêtre, AP-HP, Université Paris Saclay, Le Kremlin Bicêtre, France.
² INSERM, Centre for Research in Epidemiology and Population Health, Institut Gustave Roussy, Université Paris Saclay, Villejuif, France.

Editorial

Aurelien Amiot et al. Aliment Pharmacol Ther. 2023 Jan.

. 2023 Jan;57(1):158-159.

doi: 10.1111/apt.17260.

Aurelien Amiot^{1

2}, Antoine Meyer^{1

2}, Franck Carbonnel^{1

2}

¹ Department of Gastroenterology, Hôpitaux Universitaires Bicêtre, AP-HP, Université Paris Saclay, Le Kremlin Bicêtre, France.
² INSERM, Centre for Research in Epidemiology and Population Health, Institut Gustave Roussy, Université Paris Saclay, Villejuif, France.

No abstract available

Comment on

Pregnancy outcomes following periconceptional or gestational exposure to ustekinumab: Review of cases reported to the manufacturer's global safety database.
Mahadevan U, Naureckas S, Tikhonov I, Wang Y, Lin CB, Geldhof A, van der Woude CJ. Mahadevan U, et al. Aliment Pharmacol Ther. 2022 Aug;56(3):477-490. doi: 10.1111/apt.16960. Epub 2022 May 12. Aliment Pharmacol Ther. 2022. PMID: 35560249
Ustekinumab during pregnancy in patients with inflammatory bowel disease: a prospective multicentre cohort study.
Avni-Biron I, Mishael T, Zittan E, Livne-Margolin M, Zinger A, Tzadok R, Goldenberg R, Kopylov U, Ron Y, Hadar E, Helman S, Granovsky SG, Ollech JE, Arazi A, Farkash R, Pauker MH, Yanai H, Dotan I, Shitrit AB. Avni-Biron I, et al. Aliment Pharmacol Ther. 2022 Nov;56(9):1361-1369. doi: 10.1111/apt.17224. Epub 2022 Sep 27. Aliment Pharmacol Ther. 2022. PMID: 36168705

1. Meyer A, Drouin J, Weill A, Carbonnel F, Dray-Spira R. Pregnancy in women with inflammatory bowel disease: a French nationwide study 2010-2018. Aliment Pharmacol Ther. 2020;52:1480-90.
1. Torres J, Chaparro M, Julsgaard M, Katsanos K, Zelinkova Z, Agrawal M, et al. European Crohn's and colitis guidelines on sexuality, fertility, pregnancy, and lactation. J Crohns Colitis. 2022;jjac115. https://doi.org/10.1093/ecco-jcc/jjac115
1. Meyer A, Taine M, Drouin J, Weill A, Carbonnel F, Dray-Spira R. Serious infections in children born to mothers with inflammatory bowel disease with In utero exposure to thiopurines and anti-tumor necrosis factor. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc. 2022;20(6):1269-1281.e9. https://doi.org/10.1016/j.cgh.2021.07.028
1. Meyer A, Drouin J, Weill A, Carbonnel F, Dray-Spira R. Comparative study of pregnancy outcomes in women with inflammatory bowel disease treated with thiopurines and/or anti-TNF: a French nationwide study 2010-2018. Aliment Pharmacol Ther. 2021;54(3):302-11.
1. Avni-Biron I, Mishael T, Zittan E, Livne-Margolin M, Zinger A, Tzadok R, et al. Ustekinumab during pregnancy in patients with inflammatory bowel disease: a prospective multicentre cohort study. Aliment Pharmacol Ther. 2022;56:1361-1369.